HER2-negative breast cancer: Overview, treatment, and prognosis - negative breast


Triple-Negative Breast Cancer | CDC negative breast

Triple-negative breast cancer is cancer that tests negative for estrogen receptors, progesterone receptors, and excess HER2 protein.

A diagnosis of triple negative breast cancer means that the three most common types of receptors known to fuel most breast cancer growth–estrogen.

Triple-negative breast cancer is a rare type of breast cancer in which all receptor tests come back negative. It's serious, but it responds well to.

Triple-negative breast cancer cells do not express three markers that can play a role in breast cancer. Approximately 10% to 20% of breast cancers are.

Triple negative breast cancer is when cancer tests negative for ER, PR & HER2. Treatment will most likely be chemotherapy. Learn more at Breast Cancer Now.